SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (5920)10/26/1998 12:29:00 AM
From: Linda Kaplan  Respond to of 7041
 
Thanks, Cacaito. Nice to see you again. Your comments were informative. I hadn't thought there would be a possibility of fast track here, since Viagra is on the market. In fact, I haven't heard any longs saying this was possible. Other than SGP's influence, why would they give fast track to this? Seems rejection is possible, too, whenever the panel rules? What do you think?

--Linda



To: Cacaito who wrote (5920)10/26/1998 12:46:00 PM
From: Claud B  Read Replies (2) | Respond to of 7041
 
Cacaito,

What makes you think there will be a "panel review?"

Pfizer's Viagra did not go before a panel.

Claud


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News